Search research articles
Contact Us
Filters
Showing results (261-270 of 303) with videos related to
Page
of 31
Sort By:
Plos Pathogens
|
April 14, 2020
Fatal progression of experimental visceral leishmaniasis is associated with intestinal parasitism and secondary infection by commensal bacteria, and is delayed by antibiotic prophylaxis
Michael D Lewis, Andrea Paun, Audrey Romano, et al.
Scientific Reports
|
September 7, 2017
Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model
Norinne Lacerda-Queiroz, Nicolas Riteau, Richard T Eastman, et al.
Plos Pathogens
|
August 18, 2017
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
Katherine V Houser, Andrew J Broadbent, Lisa Gretebeck, et al.
Nature Communications
|
March 30, 2023
Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies
Mallory L Myers, John R Gallagher, Alexander J Kim, et al.
Scientific Reports
|
December 14, 2019
A primate model of severe malarial anaemia: a comparative pathogenesis study
Amber I Raja, Elizabeth B Brickley, Jessica Taaffe, et al.
Pharmacogenetics
|
February 24, 2001
Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro
J M Wong, P A Harper, U A Meyer, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
December 21, 2004
[Glossary on patient safety -- a contribution to on-target-definition and to appreciate the subjects of "patient safety"]
C Thomeczek, W Bock, D Conen, et al.
Frontiers in Immunology
|
September 29, 2023
Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
Mallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Frontiers in Immunology
|
October 17, 2022
Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
Mallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Biorxiv : the Preprint Server for Biology
|
October 7, 2024
Structure-guided assembly of an influenza spike nanobicelle vaccine provides pan H1 intranasal protection
Mallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Page
of 31
Search research articles
Search
Showing results (261-270 of 303) with videos related to
Sort By:
Page
of 31
Plos Pathogens
|
April 14, 2020
Fatal progression of experimental visceral leishmaniasis is associated with intestinal parasitism and secondary infection by commensal bacteria, and is delayed by antibiotic prophylaxis
Michael D Lewis, Andrea Paun, Audrey Romano, et al.
Scientific Reports
|
September 7, 2017
Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model
Norinne Lacerda-Queiroz, Nicolas Riteau, Richard T Eastman, et al.
Plos Pathogens
|
August 18, 2017
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
Katherine V Houser, Andrew J Broadbent, Lisa Gretebeck, et al.
Nature Communications
|
March 30, 2023
Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies
Mallory L Myers, John R Gallagher, Alexander J Kim, et al.
Scientific Reports
|
December 14, 2019
A primate model of severe malarial anaemia: a comparative pathogenesis study
Amber I Raja, Elizabeth B Brickley, Jessica Taaffe, et al.
Pharmacogenetics
|
February 24, 2001
Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro
J M Wong, P A Harper, U A Meyer, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
December 21, 2004
[Glossary on patient safety -- a contribution to on-target-definition and to appreciate the subjects of "patient safety"]
C Thomeczek, W Bock, D Conen, et al.
Frontiers in Immunology
|
September 29, 2023
Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
Mallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Frontiers in Immunology
|
October 17, 2022
Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
Mallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Biorxiv : the Preprint Server for Biology
|
October 7, 2024
Structure-guided assembly of an influenza spike nanobicelle vaccine provides pan H1 intranasal protection
Mallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Page
of 31